Here is the latest stock price and chart of Glenmark Pharma. For more details, see the Glenmark Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
FREE Subscription: Join Our YouTube Channel Today
Live BSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)578.95 | Open (Rs) 572.00 | High (Rs) 587.50 | Low (Rs) 539.00 |
% Change1.23 | Volume 700,012 | Value (Rs) 398,450,045 | 52-Week H/L 587.50 / 304.70 |
Live NSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)578.90 | Open (Rs) 570.00 | High (Rs) 587.60 | Low (Rs) 538.45 |
% Change1.22 | Volume 13,615,161 | Value (Rs) 7,767,582,946 | 52-Week H/L 587.60 / 304.50 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.23% | 1 Month 26.22% | 3 Months 14.77% | 1 Year 84.32% | 5 Years (CAGR)* -6.08% | 10 Years (CAGR)* 7.07% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 32.63 | P/E Ratio (x) 17.74 | Market Cap (Rs m) 163,361.16 | P/BV (x) 2.91 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
GLENMARK PHARMA last traded price was up 1.2% to Rs 579.0 on the BSE. On the NSE, GLENMARK PHARMA last traded price was up 1.2% to Rs 578.9. The total volume of shares traded was 14.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 47,949.4 (down 1.8%).
Over the last 30 days, the GLENMARK PHARMA share price is up 21.4%. And over the last one year, GLENMARK PHARMA share price is up 80.9%.
What else is happening in the markets today? Dig in...
Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.
For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.
For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.
Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More